Clinical trials
Observational Digestive System Diseases trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 2 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Recruiting | 6 |
| Unknown status | 6 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nanfang Hospital, Southern Medical University | 3 |
| Sun Yat-sen University | 2 |
| Beijing Tsinghua Chang Gung Hospital | 1 |
| Boston Scientific Corporation | 1 |
| Children's Hospital of Fudan University | 1 |
| Chinese PLA General Hospital | 1 |
| First Affiliated Hospital, Sun Yat-Sen University | 1 |
| Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 1 |
| Medtronic | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Digestive System Diseases | 19 |
| Cardiovascular Diseases | 3 |
| Bile Duct Diseases | 2 |
| Digestive System Neoplasms | 2 |
| Gastrointestinal Diseases | 2 |
| Gastrointestinal Neoplasms | 2 |
| Inflammatory Bowel Diseases | 2 |
| Intestinal Diseases | 2 |
| Neoplasms | 2 |
| Nervous System Diseases | 2 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.